Podcasts about medical diagnostics

Send us a textIn this episode of the Digital Pathology Podcast, I explore the evolving role of Generative vs. Non-Generative AI in Medical Diagnostics. As AI continues to transform the medical field, understanding the differences between these two approaches is essential for pathologists, researchers, and healthcare professionals.We break down the key concepts behind generative AI models (like ChatGPT and image-generation tools) and non-generative AI models (such as traditional machine learning for diagnostic support). I also highlight a groundbreaking seven-part AI review series published in Modern Pathology, which serves as a crucial reference for integrating AI into pathology.

AI and Cybersecurity: Addressing AI Myths and Strategies | Project Synapse Episode 3 Join Jim Love, host of Cyber Security Today, alongside Marcel Gagné and John Pinard in this weekend edition from our sister podcast, Hashtag Trending. This episode, part of the Project Synapse series, dives into a discussion on AI, focusing on security, strategic implementation, and addressing common myths. They explore the gap between AI strategies and their deployment, the relationship between strategy and action, and practical approaches to protect your data while utilizing AI. The conversation also touches on critical thinking and the need for proper training to make effective use of AI technology. 00:00 Introduction and Thanksgiving Break 00:31 Welcome to Hashtag Trending 00:48 Introducing Marcel Gagné and John Pinard 01:42 AI Strategy and Implementation 02:53 AI Myths and Misconceptions 06:17 AI Vulnerabilities and Security 07:27 The Role of Headlines in AI Perception 11:56 Guardrails and AI Control 16:19 Data Security and AI Models 25:07 Running Small Models on Private Networks 26:35 Leveraging Existing Tools for Cost Efficiency 28:07 Critical Thinking and AI Validation 30:53 Common Mistakes and AI Limitations 37:38 AI in Medical Diagnostics 43:04 Balancing AI Use and Human Oversight 46:37 Concluding Thoughts and Future Directions

Exploring AI Security and Strategy | Hashtag Trending Weekend Edition #3 In Episode 4 of our Project Synapse series, we delve into the intricacies of AI and generative AI, discussing pivotal issues such as AI security, corporate and departmental strategy for AI implementation, and the myths surrounding AI functionalities. Featuring insights from Marcel Gagné, an expert in open source and AI, and John Pinard, we explore the challenges companies face in deploying AI technologies, how to best utilize them, and the importance of critical thinking and prompt engineering in leveraging AI tools. Tune in for an engaging discussion on how AI is reshaping our interactions with technology and the necessary steps to harness its potential safely and effectively. 00:00 Introduction to Project Synapse 00:18 Meet Marcel Gagné: AI and Open Source Expert and John Pinard, VP and Cyber Security professional 01:10 AI Strategy and Implementation Challenges 02:18 Security Concerns in AI Deployment 04:41 Misconceptions and Myths about AI 05:46 AI in Cybersecurity: Opportunities and Risks 06:55 The Role of Headlines in AI Perception 10:34 Guardrails and Jailbreaking in AI 15:27 Data Security and AI Models 24:17 Summarizing Documents with AI 24:56 Leveraging Local Large Language Models 26:04 Maximizing Existing IT Resources 27:36 Critical Thinking in the Age of AI 28:36 AI's Role in Reducing Workload 30:23 The Importance of Validating AI Outputs 37:07 AI in Medical Diagnostics 39:56 Balancing AI and Human Judgment 42:32 Final Thoughts and Reflections

Send Everyday AI and Jordan a text message✅ OpenAI is releasing Agentic AI. ✅ Google now has the world's top AI model. ✅ And Microsoft is hours away from its biggest AI announcements of the year.  Don't waste time trying to keep up with AI on your own. We bring you the AI news that matters. Newsletter: Sign up for our free daily newsletterMore on this Episode: Episode PageJoin the discussion: Ask Jordan questions on AIUpcoming Episodes: Check out the upcoming Everyday AI Livestream lineupWebsite: YourEverydayAI.comEmail The Show: info@youreverydayai.comConnect with Jordan on LinkedInTopics Covered in This Episode:1. OpenAI's release of agentic AI2. Google's Gemini AI updates3. AI in Medical Diagnostics4. NVIDIA's Role in AI5. Microsoft Ignite EventTimestamps:00:00 Stay updated on AI developments with Everyday AI.06:15 Google restricts Gemini model to backend developers.09:10 AI training needed for medical professionals' effectiveness.11:56 NVIDIA's strong GPU demand reflects AI expansion.13:47 ChatGPT Mac updates streamline code assistance.18:32 OpenAI seeks US support for AI infrastructure.23:36 Google's Gemini and OpenAI's voice assistant lead.25:50 Google Gemini: AI voice assistant revolutionizes data access.28:26 OpenAI's Operator automates tasks with agentic AI.32:25 Google's Gemini AI: Dominant, pending update challenge.Keywords:Everyday AI, Jordan Wilson, OpenAI, AI Developments, Microsoft Ignite event, Google's Gemini AI Model, AI Model Availability, AI in Medical Diagnostics, Bloomberg, Free Course on ChatGPT, Upgrade to Gemini AI, Gemini App on iPhone, Gemini Live, Google's Notebook LM, OpenAI's upcoming AI tool Operator, Agentic AI, AI Safety, NVIDIA, AI Chips, U.S. Tariffs on Chinese Imports, OpenAI's ChatGPT Updates, North American AI Alliance, AI Economic Zones, Global AI Dynamics, Microsoft Ignite Event Broadcast, AI News, Everyday AI Newsletter, OpenAI's GPT-4, NVIDIA's Q3 Earnings, AI Discussions at Microsoft Ignite. Get more out of ChatGPT by learning our PPP method in this live, interactive and free training! Sign up now: https://youreverydayai.com/ppp-registration/

On Talk Money To Me, Felicity and Candice have spent much of the last 12 months discussing all the ways AI might impact different market sectors and transform our everyday. In this episode, they speak with two people at the forefront of the Artificial Intelligence revolution in the medical field. Professor Geoff Strange, Chief Research and Strategy Officer and Philip Woolff, Chief Operating Officer from Echo IQ. Echo IQ uses their AI-powered technology, EchoSolv to enhance the diagnosis of structural heart disease. And It's technology has seen impressive results. Felicity and Candice speak with Prof Strange and Phillip about the success of this technology, their current FDA submission, Echo IQ's strategy for commercialising EchoSolv and the implications of AI technology on the diagnostics industry. You won't want to miss this fascinating delve into the real world impacts of AI advancements. Tune in now and Lets Talk Money! Echo IQ is a listed company, their ASX ticker is EIQ. Learn more about Echo IQ hereFollow Talk Money To Me on Instagram, or send Candice and Felicity an email with all your thoughts here. Felicity Thomas and Candice Bourke are Senior Advisers at Shaw and Partners, and you can find out more here. *****In the spirit of reconciliation, Equity Mates Media and the hosts of Talk Money To Me acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people today. *****Talk Money To Me is a product of Equity Mates Media. This podcast is intended for education and entertainment purposes. Any advice is general advice only, and has not taken into account your personal financial circumstances, needs or objectives. Before acting on general advice, you should consider if it is relevant to your needs and read the relevant Product Disclosure Statement. And if you are unsure, please speak to a financial professional. Equity Mates Media operates under Australian Financial Services Licence 540697.Talk Money To Me is part of the Acast Creator Network. Hosted on Acast. See acast.com/privacy for more information.

Today, Dr. Kimberly Walker, Assistant Professor and Director of Medical Diagnostics at the University of Delaware, joins the #QualityQuorum to discuss her interesting path in microbiology, from pathogenic bacteria, to predatory microbes, to Congress, to science policy, and then to educating others about medical diagnostics. Host: Mark O. Martin Guest: Kimberly Walker Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode An article about the wonderful Microbial Diversity Course put on by the Marine Biological Laboratories at Woods Hole Massachusetts.   The website for the Microbial diversity course.  Is it not beyond merely awesome? An essay I wrote about the late Dr. Abigail Salyers. An essay I wrote about the late Dr. Edward Leadbetter. An article on the value of mentorship in general and the challenges to be faced.  If you would like to dig deeper,  here is an entire book on the vital subject.   An overview about Medical Laboratory careers. Here is a link to the Congressional Science Fellows program, for which Dr. Walker was an aide to the late Senator Paul Wellstone of Minnesota. Here is the website for Dr. Alison Weiss, Dr. Walker's PhD advisor, who was a wonderful mentor. Here is the website for Dr. Henry Williams, who was another fabulous mentor to Dr. Walker. Here is a link to the forensics lab for which Dr. Walker was on the Advisory Board. A link to Lorain County Community College, where Dr. Walker ran the MLT and Phebotomy program. A link to the University of Maryland Department of Medical and Research Technology, where Dr. Walker earned her degree and worked for ten years. Dr. Walker's faculty website. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

Digital health is an area of technology that utilises computing platforms, software, and sensors for healthcare-related issues. This includes tech categories such as wearable devices, health IT, and mobile app health. As advancements in these technological areas increase, so too does the digital integration of software and devices into life sciences and medical technologies. From this, stems many new fields in both tech and life science, such as software as a medical device. Field of Modern Science Software as a medical device is a rapidly expanding field of modern science that sees coding programmes and systems replace the functionality of many medical treatments and devices. However, with the introduction of AI to the field, are these advancements too good to be true? The current focus on AI, heralded by the development of new AI search engines and chatbots, has led to hugely increased interest in the applications of such software in most areas, and the medical device sector is no different. Within this sector exists a unique type of medical device: medical device software. This is governed and defined by several regulatory bodies, with a generally agreed definition along the lines of "software that… is intended to be used for one or more medical purposes without being part of a hardware device." Essentially, this refers to software systems or applications that perform medical tasks, such as computer-aided detection, pathogen screening, in vitro diagnostics or software that allows smartphones to view clinical imaging rather than the device performing the medical function. There is already a large market for such devices, with a market size estimated at $1048 million, but the rapid growth in the market sees a projected increase in size to $10,190 million by 2028(1), nearly a tenfold increase in just six years. Adding Artificial Intelligence While these applications are already useful for physicians and patients alike, with extremely promising growth in the space, there is a desire amongst many in the medical engineering community to push the abilities of this software further with the addition of AI. There have been several applications in which AI has been adopted to improve the efficiency of medical processes, for example, for devices such as endoscopy capsules, AI guidance systems for radiology, or irregular heartbeat warning sensors. AI can play several roles in such technologies, from an analysis tool to an active aid. For example, endoscopy capsules are ingested by the patient to take images of the gastrointestinal tract to prevent large-scale endoscopy which requires a surgery room, taking pressure off hospitals. AI becomes incredibly helpful for post-imaging analysis, where AI has been developed to flag areas of concern throughout the 24-hour or so video feed to the physician for ease of examination. This is achieved via the deep learning process, a term used in AI which refers to showing an AI a large quantity of relevant information to establish a reference database for its tasks, in this case comparing the video feed against imagery of healthy and unhealthy digestive tracts. This AI application can actually also analyse the images and suggest what conditions might be present in the flagged areas based on the knowledge accrued within their database, making the process even easier for physicians. This is where the issue of trust and reliability can emerge. Can the AI system accurately, consistently, and reliably identify all risk cases within the video feed, and is there a risk of influencing the decisions of the physician by suggesting what condition may be affecting the patient? The short answer is maybe. The future of AI within medical devices While AI systems are still developing and not every instance of a health condition will fall within two standard deviations of what the AI's knowledge database contains, the same can be said of human physicians. There is always a risk that something might be missed during...

Dr Joe is a Homeopathic Practitioner, born in Brussels, then living in several different countries before deciding to settle in New Zealand. In this podcast, he shares how he went from working as a surgeon, to discovering natural medicine – and believe me, he has studied pretty much studied every single natural health modality there is. He has also published 11 books and lectured internationally. He'll also be speaking of the Fibonacci series, which has completely revolutionised the “potency problems” many Homeopaths experience. His CV is so unbelievably amazing, that I included it here for listeners to peruse.   Dr Joe's website is www.naturamedica.co.nz and emailed at homeosensei101@gmail.com    Curriculum Vitae. Doctor Joseph Rozencwajg, MD, PhD, NMD, HMD, DO, OMD, DAcup, DIHom, DHerbMed, DNutr, HbT, FBIH, RCHom, MNZIA, MNZAMH, MNNZ, MNZSN. Born in Brussels, Belgium, March 14, 1951 Medical School Université Libre de Bruxelles, Belgium, graduated 1976 Specialty in General Surgery: 2 years at Soroka Medical Center, Beersheva, Israel   4 years various hospitals in Belgium Belgian Specialist Surgeon 1982 Specialty in Thoracic and Cardiovascular Surgery, the University of Alberta, Edmonton, Canada Diploma in Acupuncture, ABMA (Belgian School of Acupuncture for MDs)   Member of the NZ Institute of Acupuncture     Member of the NZ Chinese Medicine and Acupuncture   Society (Registered Acupuncturist)   Member of the NZ Chi-Kung and TCM Association   Certificate from the China Academy of Chinese Medicine     Sciences (Acupuncture and TCM, MEDBOO course)   Oriental Medicine Doctor (OMD) Specialist in Homeopathy:   British Institute of Homeopathy, Diploma, Post Graduate   And Fellowship   Institut Homéopathique Scientifique, Paris   Israel Medical College of Homeopathy   Westbrook University, Aztec, New Mexico, USA   Diploma in Homotoxicology   PhD in Homeopathy, Westbrook University   RCHom New Zealand     Specialist in Phytotherapy (Herbal Medicine):   The School of Phytotherapy, UK  Member of the NZ Association of Medical Herbalists Diploma in Nutrition: the International Academy of Nutrition, Australia Diploma in Applied Clinical Nutrition (USA) Fellow of the American College of Applied Clinical Nutritionists Diploma in Homeobotanical Therapy, Australia Post-Graduate Diploma of Dynamic Phytotherapy  Doctor in Naturopathy (UNM/YINS) PhD in Natural Health Sciences (UNM/YINS) Doctor in Oriental Medicine (OMD, Calamus International University) Doctorate in Osteopathy (Drugless) (D.O.) Permanent student in Ortho-Bionomy Student in Cranio-Sacral Therapy Student in Visceral Manipulation Advanced Dorn Method Practitioner Miscellaneous: Auriculotherapy, Bach Flower Remedies, Aromatherapy,    Reflexology, Iridology, Reiki Master (Usui), MPRUE Great GrandMaster Practitioner and Instructor in Tai Chi and Qigong. Former Lecturer in Medical Diagnostics at the Faculty of Chiropractics and Homeopathy, Technikon Natal, Durban, South Africa. Former Lecturer in Homeopathy at the Israeli Medical College of Homeopathy. Former Tutor with the British Institute of Homeopathy (Homeopathy, Anatomy & Physiology, Pathology, Diagnostics and Nutrition) Professor of Natural Medicine at Calamus International University Publications: - Dynamic Gemmotherapy. Integrative Embryonic Phytotherapy. - Organotherapy, Drainage and Detoxification. - Removing the guesswork from potency selection: the Fibonacci Potencies series (paper). - The Fibonacci Series: update, discussion and conclusions (paper). - The Potency. Advanced prescribing in homeopathy: the Fibonacci Series. - Third Millennium Homeopathy - Homeopathy and Mental Health Care: Chapter 16 of this Anthology - Homeopathy through the Chinese looking glass: Homeosiniatry revisited - Elementary Nutrition for Homeopaths - Elementary Human Nutrition for Health Practitioners   Non-Medical qualifications: Diploma of Creative Writing from the NZ Institute of    Business Studies. Certificate in Mauri Ora (Maori studies) from Te Wananga O Aoteaora   First Dan Black Belt Aikido   Second Dan Black Belt Karate   Tai Chi Chuan and Qigong Practitioner   Yoga Student/Practitioner

Derek Herrera, founder and CEO of Bright Uro, grew up in a military family with a curious mind and a skill for building things. After graduating, he entered the Naval Academy, studied systems engineering and robotics, and became a Special Operations Marine Raider. When an injury left him paralyzed from the waist down, he launched a new career to improve the lives of spinal cord injury patients through medical innovation.   Herrera speaks with podcast host Geoff Pardo about his extensive military career and the leadership skills fostered during that time. He also talks about his first entrepreneurial pursuit creating a fully internal and remotely controlled device for chronic urinary retention, a common issue for spinal cord injury patients. Herrera discusses his new business, Bright Uro, which leverages advanced technology to create urological diagnostic devices. He says, “Not only will we offer a superior patient and customer user experience, a more comfortable technology, and improve clinical efficiency, we're unlocking data that's never been obtained before because there's never been the capability to do so.” Links from this episode:  Gilde Healthcare Bright Uro UroDev Medical 

We have two special announcements!Very soon we will be celebrating a decade of DNA Today! That's right, we released our first episode on September 1st, 2012. It also coincides with our 200th episode. We want to mark these milestones with you on the show. So send in your favorite episode. You can write it, or better yet, record a voice memo sharing your favorite episode and why you enjoy listening to the show. After all, our podcast would not be possible without you loyal listeners. That's why we want to celebrate together! Send in your voice memo or written message about your fav episode of DNA Today to info@dnapodcast.com. Deadline is August 27th.Thank you to all you listeners for nominating us in the Podcast Awards, you did it! We have officially been nominated. It's year number 6 being nominated and it might be our third time winning the Best Science and Medicine Podcast Award. BUT that's only gong to happen if you check your email inbox for an email from The Podcast Awards with the subject line, “Podcast Awards Final Slate Voting”'. If you got this email you are one of the few that were selected to be a voter. It's imperative that you vote! There is a hyperlink to click to get to the voting page. You do have to quickly log back in. Once you do, select DNA Today in the “Science and Medicine category”, select your other fav podcasts and then Hit the “Save Nominations” button. It's that easy. You have until September 10th to do this, but please do it now if you got the email so you don't forget! Can't thank you all enough! Special shoutout to the following listeners for sharing after they nominated us…Heather, Dan, Janelle, Steven, Doug, Lynn, Taila, Lorraine, Katherine, Barbara, Jerry, Catherine, Kim, Ashlyn, Pricilla, Jane, Rob, Hari, Vishnu, Leticia, Meli, Wright, Mahfuz, Anne, Laura, Molly, Hibat, Rachael, Carol, Hal, Romer, JoanneJoining us this week is Dr. Kiana Aran, Associate Professor of Medical Diagnostics and Therapeutics and head of the Aran Lab at Keck Graduate Institute (KGI) where she works to develop CRISPR Quality Control standards.In addition to her important work at KGI, Dr. Aran is also the Chief Scientific Officer of Cardea Bio, is a visiting Assistant Professor at UC Berkeley, and serves as a Consultant of Drug Delivery and Medical Diagnostics for the Bill & Melinda Gates Foundation. She received her undergraduate degree in electrical engineering from the City University of New York in 2007 and her Ph.D. in Biomedical Engineering at the Rutgers University in 2012. She then continued her postdoctoral studies in bioengineering at the University of California, Berkeley and was a recipient of the National Institutes of Health (NIH) postdoctoral training fellowship at the Buck Institute for Aging Research in 2015. Her efforts have been recently recognized by many awards in science and STEM including the Clinical OMICs 10 under 40 Award and the Athena Pinnacle Award. Dr. Aran was also the recipient of the NSF Career Award to develop the next generation of electronic sensors, and Nature's Scientific Achievment Award in 2021.On This Episode We Discuss:What is CRISPR and how does it work? How CRISPR is different from other genetic editing technologiesCurrent standards for therapeutic applications using CRISPRPotential side effects of CRISPR treatmentsThe risk for off target CRISPR'd edits (edits in other genes that were not intended)The CRISPR Quality Control standards that Dr. Aran's lab is developingCRISPR-ChipTMApplications of CRISPR-Cas systems beyond genome editingPredicting when CRISPR treatments will be clinically available outside of studiesCRISPR babiesDr. Aran's most recent NIH grant and future workLearn more about Dr. Aran's research by visiting aranlab.org and read about her 1.63 million dollar NIH grant to help set Quality Control Standards for CRISPR Therapies! You can also read the paper that she co-authored in The CRISPR Journal about applications of CRISPR-Cas systems beyond genome editing in 2021. Follow Dr. Aran on Twitter and LinkedIn, and follow the Aran lab on Instagram!Stay tuned for the next new episode of DNA Today on August 19th, 2022 where we'll be joined by Sam Sternberg, co-author of A Crack in Creation (who he wrote with Nobel Prize winner, Jennifer Doudna), to continue our discussion about CRISPR! New episodes are released on Fridays. In the meantime, you can binge over 195 other episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Today”. Episodes since 2021 are also recorded with video which you can watch on our YouTube channel. DNA Today is hosted and produced by Kira Dineen. Our social media lead is Corinne Merlino. Our video lead is Amanda Andreoli. See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, DNApodcast.com. Questions/inquiries can be sent to info@DNApodcast.com. PerkinElmer Genomics is a global leader in genetic testing focusing on rare diseases, inherited disorders, newborn screening, and hereditary cancer. Testing services support the full continuum of care from preconception and prenatal to neonatal, pediatric, and adult. Testing options include sequencing for targeted genes, multiple genes, the whole exome or genome, and copy number variations. Using a simple saliva or blood sample, PerkinElmer Genomics answers complex genetic questions that can proactively inform patient care and end the diagnostic odyssey for families. Learn more at PerkinElmerGenomics.com. (SPONSORED)

Today's episode explores disruptive healthcare technologies in neurodegenerative diseases hosted by David Ferguson, Underwriting Development Manager in one of SCOR's Innovation Teams. Our guest is Professor Stephen Smith, co-founder and director of ClearSky Medical Diagnostics and Professor of Electronic Engineering in the Department of Electronics at University of York. 1 in 4 people get a misdiagnosis in Parkinson's disease which can lead to an overtreatment. Professor Smith highlights the importance of an accurate diagnosis in neurodegenerative diseases. ClearSky MD provides the PD-Monitor assisting specialists by measuring and identifying symptoms of Parkinson's disease. Finding a tolerable balance between unpleasant side effects of the medication and its benefits is another focus. The LID-Monitor (Levodopa-induced dyskinesia) offers a safe and simple way of monitoring dyskinesia in the patient's own home. ClearSky MD's solutions empower patients to have the tools track their own conditions remotely with clear implications for how life & health insurance products are sold and monitored.

Materials Science and Engineering Professor Perena Gouma joins Dean Ayanna Howard. She leads a team of Ohio State researchers developing a device capable of detecting viruses – including SARS-CoV-2 – with just a single exhaled breath. If you've had the distinct displeasure of a nasal swab test, you're surely looking forward to a faster, easier,… Continue reading Ep. 4: Breathing innovation into medical diagnostics

Guest: Ashley Uys | Managing director at Medical Diagnostech The first locally-produced antigen test for Covid recently received approval and is being manufactured here in Cape Town by a company called Medical Diagnostics. Founder and CEO Ashley Uys from Belhar says they are up to 50 percent cheaper than the cheapest product being used by medical professionals.  See omnystudio.com/listener for privacy information.

Know Labs has their trademarked Bio-RFID platform that will change how we analyze and monitor molecules non-invasively. They've built and designed a platform utilizing wearable and mobile devices The initial focus of their technology is a glucose monitoring device and they have plans to further develop their devices, and their platform. I talk withe the Founder/Chairman, Ron Erickson and Chief Medical Officer, Dr. James "Andy" Anderson, about their work (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today introduced the KnowU™, a new portable medical-grade glucose monitoring device that utilizes Bio-RFID™, Know Labs' non-invasive diagnostic technology. --- Send in a voice message: https://podcasters.spotify.com/pod/show/hicksnewmedia/message Support this podcast: https://podcasters.spotify.com/pod/show/hicksnewmedia/support

Know Labs has their trademarked Bio-RFID platform that will change how we analyze and monitor molecules non-invasively. They've built and designed a platform utilizing wearable and mobile devices The initial focus of their technology is a glucose monitoring device and they have plans to further develop their devices, and their platform. I talk withe the Founder/Chairman, Ron Erickson and Chief Medical Officer, Dr. James "Andy" Anderson, about their work (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today introduced the KnowU™, a new portable medical-grade glucose monitoring device that utilizes Bio-RFID™, Know Labs' non-invasive diagnostic technology. --- Send in a voice message: https://anchor.fm/hicksnewmedia/message Support this podcast: https://anchor.fm/hicksnewmedia/support

Dr Joe is a Homeopathic Practitioner, born in Brussels, then living in several different countries before deciding to settle in New Zealand. In this podcast, he shares how he went from working as a surgeon, to discovering natural medicine – and believe me, he has studied pretty much studied every single natural health modality there is. He has also published 11 books and lectured internationally. He'll also be speaking of the Fibonacci series, which has completely revolutionised the “potency problems” many Homeopaths experience. His CV is so unbelievably amazing, that I included it here for listeners to peruse.   Dr Joe's website is www.naturamedica.co.nz and emailed at homeosensei101@gmail.com    Curriculum Vitae. Doctor Joseph Rozencwajg, MD, PhD, NMD, HMD, DO, OMD, DAcup, DIHom, DHerbMed, DNutr, HbT, FBIH, RCHom, MNZIA, MNZAMH, MNNZ, MNZSN. Born in Brussels, Belgium, March 14, 1951 Medical School Université Libre de Bruxelles, Belgium, graduated 1976 Specialty in General Surgery: 2 years at Soroka Medical Center, Beersheva, Israel   4 years various hospitals in Belgium Belgian Specialist Surgeon 1982 Specialty in Thoracic and Cardiovascular Surgery, the University of Alberta, Edmonton, Canada Diploma in Acupuncture, ABMA (Belgian School of Acupuncture for MDs)   Member of the NZ Institute of Acupuncture     Member of the NZ Chinese Medicine and Acupuncture   Society (Registered Acupuncturist)   Member of the NZ Chi-Kung and TCM Association   Certificate from the China Academy of Chinese Medicine     Sciences (Acupuncture and TCM, MEDBOO course)   Oriental Medicine Doctor (OMD) Specialist in Homeopathy:   British Institute of Homeopathy, Diploma, Post Graduate   And Fellowship   Institut Homéopathique Scientifique, Paris   Israel Medical College of Homeopathy   Westbrook University, Aztec, New Mexico, USA   Diploma in Homotoxicology   PhD in Homeopathy, Westbrook University   RCHom New Zealand     Specialist in Phytotherapy (Herbal Medicine):   The School of Phytotherapy, UK  Member of the NZ Association of Medical Herbalists Diploma in Nutrition: the International Academy of Nutrition, Australia Diploma in Applied Clinical Nutrition (USA) Fellow of the American College of Applied Clinical Nutritionists Diploma in Homeobotanical Therapy, Australia Post-Graduate Diploma of Dynamic Phytotherapy  Doctor in Naturopathy (UNM/YINS) PhD in Natural Health Sciences (UNM/YINS) Doctor in Oriental Medicine (OMD, Calamus International University) Doctorate in Osteopathy (Drugless) (D.O.) Permanent student in Ortho-Bionomy Student in Cranio-Sacral Therapy Student in Visceral Manipulation Advanced Dorn Method Practitioner Miscellaneous: Auriculotherapy, Bach Flower Remedies, Aromatherapy,    Reflexology, Iridology, Reiki Master (Usui), MPRUE Great GrandMaster Practitioner and Instructor in Tai Chi and Qigong. Former Lecturer in Medical Diagnostics at the Faculty of Chiropractics and Homeopathy, Technikon Natal, Durban, South Africa. Former Lecturer in Homeopathy at the Israeli Medical College of Homeopathy. Former Tutor with the British Institute of Homeopathy (Homeopathy, Anatomy & Physiology, Pathology, Diagnostics and Nutrition) Professor of Natural Medicine at Calamus International University Publications: - Dynamic Gemmotherapy. Integrative Embryonic Phytotherapy. - Organotherapy, Drainage and Detoxification. - Removing the guesswork from potency selection: the Fibonacci Potencies series (paper). - The Fibonacci Series: update, discussion and conclusions (paper). - The Potency. Advanced prescribing in homeopathy: the Fibonacci Series. - Third Millennium Homeopathy - Homeopathy and Mental Health Care: Chapter 16 of this Anthology - Homeopathy through the Chinese looking glass: Homeosiniatry revisited - Elementary Nutrition for Homeopaths - Elementary Human Nutrition for Health Practitioners   Non-Medical qualifications: Diploma of Creative Writing from the NZ Institute of    Business Studies. Certificate in Mauri Ora (Maori studies) from Te Wananga O Aoteaora   First Dan Black Belt Aikido   Second Dan Black Belt Karate   Tai Chi Chuan and Qigong Practitioner   Yoga Student/Practitioner

This episode I'll be speaking with the brilliant Oluwasoga Oni. I simply call him Soga. He is CEO and co-founder of MDaaS Global. A company based in Lagos, Nigeria that provides tech-enabled diagnostic centers that are to designed to cater to the needs of underserved communities. Soga is an engineer. He holds two Masters degrees. One in Computer Science and the other in Engineering, System Design and Management from MIT. You can learn more about MDaaS by visiting https://www.mdaas.io/ or on Twitter and LinkedIn @mdaasglobal. If you have any thoughts on this episode, or recommendations of African health innovators that you'd like me to host on the show, please reach out to me directly on Twitter @DrSam_Oti, email: sam.oti@alumni.harvard.edu or via LinkedIn https://www.linkedin.com/in/samuel-oji-oti. Please note that The MedxTek Africa Podcast is distinct from Dr. Oti's role as a Senior Program Specialist at Canada's International Development Research Centre. The information provided in this podcast is not medical advice, nor should it be construed or applied as a replacement for medical advice. The MedxTek Africa Podcast, its production team, guests and partners assume no liability for the application of the podcast's content.

Episode: 2709 IBM's Watson and the aftermath of winning Jeopardy!  Today, is it bigger than a bread box?

In this episode, Scott and Frank host Jovan Leach to the lounge. Jovan is an Air Force Senior Enlisted Leader, who has served for 23 years and is currently the Squadron Superintendent at the 59th Medical Diagnostics & Therapeutics Squadron at Wilford Hall Medical Center, JBSA-Lackland. He is a Nutritional Medicine Airman who has also served in developmental special duties which include, Air Force Recruiting Service and Superintendent, Complaint Resolutions for the Office of the Inspector General. Together we covered how we overcome egotistical tendencies in our lives and how we find our purpose. Jovan's Book Recommendations: Call Sign Chaos: Learning to Lead- Bing West and James N. Mattis: https://amzn.to/3yBi9bW How to Win Friends and Influence People- Dale Carnegie: https://amzn.to/38FTxnT Other resources discussed in this episode: The Way, the Enemy, and the Key: A Boxed Set of The Obstacle is the Way, Ego is the Enemy, & Stillness is the Key- Ryan Holiday https://amzn.to/3DzF4ru Connect with Jovan Leach here: https://www.linkedin.com/in/jovan-jo-jo-leach-41588373/ https://www.facebook.com/jovan.leach.92 Check out our show sponsor: This episode is brought to you by Blazing Star BBQ! https://www.blazingstarbbq.com/ Blazing Star BBQ is a veteran owned business owned and operated by Mike Starr, a veteran of more than 20 years of service to our nation. Mike is devoted to “Bringing unique flavors from his world travels to your backyard!” Check out his delicious rubs and sauces. You won't be disappointed!

On this week's Tech Nation, Moira speaks with DR. HARVEY KAUFMAN, the Senior Medical Director of Quest Diagnostics, about how the use or delay of medical tests reveals about the health status of the US. Then MIKE CLAYMAN, the CEO of Flexion Therapeutics, talks about the treatments they have in clinical trials for osteoarthritis, knee replacement surgery, and more.

On this week's Tech Nation, Moira speaks with DR. HARVEY KAUFMAN, the Senior Medical Director of Quest Diagnostics, about how the use or delay of medical tests reveals about the health status of the US. Then MIKE CLAYMAN, the CEO of Flexion Therapeutics, talks about the treatments they have in clinical trials for osteoarthritis, knee replacement surgery, and more.

Joseph Opoku speaks with Dr Michael Owusu, clinical microbiologist and lecturer at the Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Ghana https://allianceforscience.cornell.edu/alliance-for-science-live/event/covid-vaccine-whats-at-stake-for-africa/ As wealthy nations hoard COVID-19 vaccine supplies, Africa is lagging in the global effort to immunize people against the disease even as its fatality numbers spike. Though Africa has 17 percent of the world's population, it accounts for just 0.2 percent of the 209 million doses of COVID-19 vaccines administered to people across the globe. Meanwhile, the continent is experiencing a sharp rise in COVID infections and fatalities. As of Feb. 22, some 2.66 million doses had been administered to people living in at least seven of Africa's 55 countries, according to data from Bloomberg that the Alliance for Science analyzed. By comparison, the United States had administered 64.28 million doses by that same date and the United Kingdom had given 18.34 million doses. Israel has administered 7.4 million doses, China 40.5 million doses and Russia 2.2 million doses, according to the Bloomberg tracker. South Africa President Cyril Ramaphosa, who is also chairman of the African Union, recently called on wealthy nations to make more COVID-19 vaccines available to the rest of the world. He criticized them for hoarding vaccine supplies. “The rich countries of the world went out and acquired large doses. Some even acquired up to four times what their population needs … to the exclusion of other countries,” Ramaphosa observed during a virtual meeting of the World Economic Forum. The European Union has ordered 525 million more full vaccinations than will be needed to vaccinate all its population, said Robin Cohen, a professor of development studies at the University of Oxford, after analyzing data from the Duke Health Innovation Center. The UK has ordered 65 million surplus full vaccinations, while Canada has ordered 156 million excess full vaccinations. Other wealthy nations have similarly ordered doses far in excess of what they need. The African Union recently announced it has secured 400 million doses of coronavirus vaccines for the continent under COVAX, a World Health Organization initiative, bringing the total number of COVID-19 doses secured for Africa to 1.27 billion doses. However, it could take years before all those doses become available and at least 1.5 billion doses will be needed to vaccinate just 60 percent of the continent's population.

Did you know that there is more than $100 million worth of capital available to Arizona entrepreneurs right now?  Were you aware that Tucson ranks as one of the Top 5 Cities for entrepreneurs, according to Entrepreneur magazine, but it has been a long, hard road.  I find it incredible that within the last few years, Tucson has gone from only one or two venture capital firms to over five.  One of those firms is BlueStone Venture Partners where managing partner Mara Aspinall and team are utilizing their “Noses in, fingers out” approach to invest in regional digital health, medical devices  and medical diagnostics startups.  Their Fund primarily focuses on companies that reside within five key verticals including: Medical Devices, Advanced Materials, Healthcare IT, Diagnostics, and Biopharma Platforms.As an entrepreneur, I really appreciate Mara’s hyper-focus on startup teams over technology.  To create an A-Team (insert theme music here) you must:Know your strengths and most importantly your weaknesses.  If you can’t articulate these, how will you be able to build a team that has strengths to counter-balance your weaknesses? Find the right team,: these should be people you trust, and that can consistently be intellectually honest with you.   These team members should also be highly adept at navigating ambiguity as it’s likely to be all your startup will be facing for the first few years.After building your A-Team,  go “do your homework”. Your goal should be to understand your situation and potential future scenarios enough to anticipate what’s coming.  This will help you and the team mitigate the foreseeable errors, and hopefully not worry about the ones you could not have known.   Most importantly, get moving and keep moving.   About MaraAspinall is a healthcare industry leader and pioneer committed to active civic involvement. She is Managing Director and Co-Founder of BlueStone Venture Partners, a venture fund investing in life sciences technology companies in the US Southwest. She is also Managing Director of the Health Catalysts Group, a consulting firm dedicated to the growth of health information technology and diagnostics firms, publishing the popular Health Catalysts Diagnostics Year in Review. She is a member of the Board of Directors of Abcam plc (ABC), Allscripts (MDRX), Castle Biosciences (CSTL), Orasure (OSUR), and Blue Cross Blue Shield Arizona. Most recently, Aspinall was certified in Cybersecurity Oversight from Carnegie Mellon University.As President and CEO of Ventana Medical Systems, a billion-dollar division of The Roche Group, (now Roche Tissue Diagnostics) Aspinall led her world-class team to new financial success, more than two dozen major instrument and assay launches as well as global leadership in companion diagnostics.  Previously, Aspinall spent 13 years at Genzyme Corporation where she served as President of Genzyme Genetics and Genzyme Pharmaceuticals. Genzyme Genetics was a leading provider of diagnostic testing and genetic counseling in the oncology and reproductive markets. Aspinall transformed the business from a small specialized player to one of the top five laboratories in the country while setting the industry standard for quality testing. The business was sold to LabCorp for nearly $1billion. Previously, she led Genzyme Pharmaceuticals and its transformation to an international leader in specialized pharmaceutical ingredient manufacturing. 

Sujal Patel is the cofounder and CEO of Nautilus Biotechnology which offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome. The company has raised over $100 million from top tier investors such as Andreessen Horowitz, Madrona Venture Group, AME Cloud Ventures, Vulcan Capital, Perceptive Advisors, Bezos Expeditions, Bolt Ventures, and Defy Ventures to name a few.  Prior to this, he cofounded Isilon which he sold to EMC for $2.6 billion. 

Sujal Patel is the cofounder and CEO of Nautilus Biotechnology which offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome. The company has raised over $100 million from top tier investors such as Andreessen Horowitz, Madrona Venture Group, AME Cloud Ventures, Vulcan Capital, Perceptive Advisors, Bezos Expeditions, Bolt Ventures, and Defy Ventures to name a few.  Prior to this, he cofounded Isilon which he sold to EMC for $2.6 billion. 

Jon Denny has been a NATIONAL Executive Sales & Marketing Recruiter for over 21+ years in the MEDICAL, DIAGNOSTIC, PHARMACEUTICAL & BIOTECH Industries with a leading National Recruitment firm Buckman Enochs Coss & Associates established in 1979. Specialize in Medical Device, Medical Diagnostics, Pharmaceutical and Biotech Sales & Marketing Executive Search.  BEC partners in finding talent for leading Healthcare Companies such as: ACADIA Pharmaceuticals, Allergan/Abbvie, Ambry Genetics, Amgen, Boston Scientific, Cardinal Health, Dompe, Genentech, and many others. Prior to joining BEC Jon spent over 2 years in Accounting and Finance Recruitment for a leading staffing firm and 4 years in College/University Recruitment. In the last Two Decades, Jon has helped countless individuals in healthcare sales, marketing, and clinical roles find employment opportunities that have been life-changing and he has several current clients he helped early on in their careers.  He attributes his Business Acumen, Strong Work Ethic, Empathy and Connecting with Individuals from his competitive collegiate athletic background playing 4 Years of Football at his alma mater, Ohio Northern University. What you'll learn about in this episode: How a dinner conversation at a client's awards event helped him understand the enormous impact he could have on the lives of the people he placed. Why humility is such a critical skill and the different coaches an experiences that taught him that lesson. What really motivates people when they are evaluating new career opportunities. How past performance is a measure of future success. What positives opportunities have showed up in his life during the COVID-19 pandemic. What are the characteristics that top companies in the Medical, Diagnostic, Pharmaceutical, and Biotech industries are looking for when they are hiring front-line leaders. Why mental toughness is so critical in growing through adversity and how those lessons help you persevere. Additional resources: Company Website: www.becsearch.com  LinkedIn: https://www.linkedin.com/in/jondennybec/ Company Facebook Page: https://www.facebook.com/becsearch/  Instagram: https://www.instagram.com/becsearch Company LinkedIn: https://www.linkedin.com/company/buckman-enochs-coss-&-associates/ Your Twitter Name: Personal: @denny_jon Company Twitter Name: @becsearch Your LinkedIn Profile: https://www.linkedin.com/in/jondennybec/ Charity Fundraising for Cancer Research: https://pelotonia.org/ *Founded in 2008, Pelotonia was established with the objective to fund life-saving cancer research. Through the first 11 years, the Pelotonia community raised more than $207 million for cancer research. Thanks to its generous funding partners, Pelotonia is able to direct 100% of every participant raised dollar to cancer research at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute.

In this episode our hosts discuss the implications of remote health monitoring. Would you be more or less comfortable knowing that your health-related data is being fed into a system designed to monitor your vital signs and track associated behaviors in order to provide early detection of worrisome changes in your health?Public Health MonitoringSome municipalities are already analyzing effluent to monitor public health and behavior. As far back as 2002, fourteen Canadian cities found traces of pharmaceutical products in waste water. More recently, in Massachusetts, high concentrations of SARS-CoV-2 were found in water collected at a major sewage treatment facility.Social Responsibility and Big BusinessThe importance of a reliable and responsive health care system is underscored with every passing day, as we battle a global pandemic. Unlikely players, tech and data giants, are now interested in a piece of the action.Individual Self-Monitoring Many individuals are looking to be proactive, rather than reactive, when it comes to their health. Companies are already leveraging the power of wearable devices to provide information on vitals such as heart rate, respiration, cadence and walking distance, but would you want to tie that to information pulled from your medical records, currently held by hospitals and health clinics?Public TracingSeveral countries are in the spotlight and are generating controversy due to their public tracing programs that use data from personal cell phones. Would you be willing to opt in and allow tracking of your movement in order to provide important information related to virus transmission?For more information check out Humanatronix.com

What if AI could say you don't need a risky heart surgery like the doctor prescribed? Or what if it could help identifying cancer in an X-ray with higher accuracy at an earlier stage? Sounds like the future, but American startup Arterys is doing this already in 28 countries. Want to know how? In our SCOR Life and Health Innovation Podcast we're exploring medical imaging, cancer, Covid-19, and how doctors can get some little help from their AI friend to improve patient journey and get the best treatments and diagnosis faster than ever.

Why is the health care system so poorly set up to handle chronic disease? What interesting technologies are on the horizon—specifically in medical diagnostics—that might be able to change this and be promising venture investments? James Wang, General Partner at Creative Ventures, is joined by Chidi Nwankpa, MD, Summer Associate at Creative Ventures, formerly a practicing physician in Texas, and MBA at the Chicago Booth School of Business.During this summer, Chidi's project analyzed opportunities and challenges in the medical diagnostics space, and she shares some of her findings here. 

Today we have the opportunity to share a rebroadcast of the CRISPR Cuts podcast interview with Kiana Aran, who is a KGI Assistant Professor of Medical Diagnostics and Therapeutics. If you enjoy the KGI and the CRISPR Cuts podcasts, visit those podcast pages on iTunes and be sure to subscribe and leave a review so we can reach more listeners! Here is the link to the CRSPR Cuts podcast interview featuring Kiana Aran.

Das et al, Artificial Intelligence, Medical Diagnostics and the Limits of Certainty by Centre for Ethics, University of Toronto

Episode Summary: Recently, we were called upon by the World Bank to do a good deal of research on the potential of applying artificial intelligence to health data in the developing world. Diagnostics was a very big focus of the information that we presented. It appears as though diagnostics is an area of great promise with regards to AI, and that's what we're focusing on in this episode the podcast. This week, we speak with Yufeng Deng, Chief Scientist of Infervision, a company that focuses on computer vision for medical diagnostics. We speak with Deng about the expanding capability of machine vision, including what kind of data one needs to collect and what is now possible with the technology. In addition, Deng also speaks about how Infovision found a business problem to solve using AI, and in that he provides transferable lessons to business leaders in a variety of industries.

Genevieve is the Co-Founder of MDaaS Global, a start-up providing convenient, affordable, and high-quality diagnostics and primary care for Africa's next billion, starting in Nigeria. In this episode, learn how Genevieve immersed herself in the world of public health and noticed one major flaw in the way the system was working. You'll also hear about her experience as a female founder, why having a systems mindset is so crucial, and what it's like when your partner in business is also your partner in life!

Future of Everything with Russ Altman "Euan Ashley: Exploring a new age of medical diagnostics" Stanford’s Russ Altman and Euan Ashley discuss wearable technology, data and the extraordinary challenges of undiagnosed disease. Originally aired on SiriusXM on September 9, 2017.

In the Future of Everything radio show, Stanford's Russ Altman and Euan Ashley discuss wearable technology, data and the extraordinary challenges when diagnoses elude physicians and their patients. Ashley is a professor of medicine (cardiovascular) and by courtesy, of pathology at the Stanford University Medical Center. Listen to more episodes of the Future of Everything with host, bioengineering professor Russ Altman.

Dr. David Gane is a graduate of the University of Western Ontario with an honors degree in physiology & pharmacology and a doctorate degree in dental surgery.   David has authored many publications and technique videos on digital dental imaging and has lectured nationally and internationally on this topic.  He is a recognized leader in the dental profession and is also a corporate executive with extensive experience in dental technology.  He is the former Vice President of Dental Imaging for Carestream Dental LLC and has served in executive capacities with a number of dental companies including Practiceworks LLC and Kodak Dental Systems and is the founder of Orbit Imaging Inc., a company that owns and operates dental imaging centers in Vancouver.   Dr. Gane currently serves as CEO of LED Medical Diagnostics, the manufacturer of the VELscope and the parent company of LED Dental and Apteryx Inc.   www.LEDDental.com

The Future of Everything With Russ Altman "Audrey Bowden: What is the future of medical diagnostics?" On the Future of Everything radio show, Stanford’s Russ Altman and electrical engineering professor Audrey Bowden discuss at-home urinalysis, bladder cancer diagnosis, and how hearing works. Originally aired on March 25, 2017 on SiriusXM.

Forget WebMD, a new technology will soon make it possible to bring a diagnosis lab into your bathroom. On the Future of Everything radio show, Stanford's Russ Altman and electrical engineering professor Audrey Bowden discuss patient empowerment and the future of medical diagnostics.

The X-Ray phase-contrast techniques are innovative imaging methods allowing overtaking the limitations of classic radiology. In addition to the differential X-ray absorption on which standard radiology relies, in phase-contrast imaging the contrast is given by the effects of the refraction of X-rays inside the tissues. The combination of phase-contrast with quantitative computer tomography (CT) allows for a highly accurate reconstruction of the tissues’ index of refraction. Thanks to the high sensitivity of the method, tomographic images can be obtained at clinically compatible dose. For all these reasons phase-contrast imaging is a very promising approach, which can potentially revolutionize diagnostic X-Ray imaging. Several techniques are classified under the name of X-Ray phase-contrast imaging. This Thesis focused on the so-called analyzer-based imaging (ABI) method. ABI uses a perfect crystal, placed between the sample and the detector, to visualize the phase effects occurred within the sample. The quantitative reconstruction of the refraction index from CT data is not trivial and before this Thesis work it was documented only for small size objects. This Thesis has focused on two main scientific problems: (1) the development of theoretical and calculation strategies to determine the quantitative map of the refraction index of large biological tissues/organs (>10 cm) using the ABI technique; and (2) the preparation of accurate and efficient tools to estimate and simulate the dose deposited in CT imaging of large samples. For the determination of the refraction index, two CT geometries were considered and studied: the out-of-plane and the in-plane configurations. The first one, the most used in the works reported in the literature, foresees that the rotation axis of the sample occurs in a plane parallel to that of the sensitivity of the analyzer crystal; while, in the second CT geometry, the rotation axis is perpendicular to that plane. The theoretical study, technical design and experimental implementation of the in-plane geometry have been main tasks of this Thesis. A first experiment has been performed in order to compare the results obtained with in-plane quantitative phase contrast CT with the absorption-based CT ones. An improved accuracy and a better agreement with the theoretical density values have been obtained by exploiting the refraction effect while keeping the dose to sample low. A second campaign of experiments has been performed on large human breasts to investigate the efficiency of the in-plane and out-of-plane CT geometries and the performances of the associated image reconstruction procedures. The same experimental conditions were also studied by numerical simulations and the results were compared. This analysis shows that the in-plane geometry allows producing more accurate quantitative three dimensional maps of the index of refraction, while the out-of-plane case is preferable for qualitative investigations. A study for developing advanced procedures for improving the quality of the obtained CT images has been also conducted. As a result, a two-step procedure has been tested and identified: first the noise level of the experimental images is reduced by applying a wavelet decomposition algorithm and then a deconvolution procedure. The obtained images show an enhanced sharpness of the interfaces and of the object edges and high signal to noise ratio values are preserved. The second problem of this Thesis was to find strategies to calculate, in a fast way, the delivered dose in CT imaging of complex biological samples. For this purpose an acceleration method to speed-up the convergence of Monte Carlo simulations based on the Track Length Estimator method has been computed and included in the open-source software GATE. Results show that this method can lead to the same accuracy of conventional Monte Carlo methods while reducing the required computation time of up to two orders of magnitude, with the respect to the considered geometry. A database of dose curves for the case of monochromatic breast CT has been produced: it allows for a quick estimation of the delivered dose. A way to choose the best energy and the optimal photon flux was also proposed, which leads to a significant reduction of the delivered dose without any loss in terms of image quality. Most of the experimental and data reconstruction methods developed within this Thesis work can be applied also to other phase-contrast techniques. This Thesis shows that high resolution three dimensional diagnostic imaging of large and complex biological organs can, in principle, be performed at clinical compatible doses; this is the most significant contribution of the Thesis towards the clinical implementation of phase-contrast CT.

Professors Anton Amman and Agapios Agapiou speak about their effort to use breath and sweat of humans as an innovative tool for targeted clinical diagnostics – kind of an odour-CSI...Their ambitious goal is to develop a personalized mobile telemedicine application that could recognise, using special and elaborate sensors, volatiles (which is quite a feat, as we may easily pinpoint only a handful of them) and alert people if something is not as it should be... Interviewed by Yannis Rizopoulos for Tech Talks Central.

On the Wednesday May 28th 2014 broadcast at 12 Noon Pacific/3PM Eastern time my special guest is John Lynch publisher of the blog 'Our Healthcare Sucks'. John Lynch was founder and CEO of Medical Diagnostics, inc. - twice named to Business Week's "Best Small Companies" in America. He's since founded MedSmart Members to publish consumer health education publications. More about John here. We'll talk about the ACA, accountable care and the status of health reform. Join us!  

Scholarship@Villanova - Outstanding Faculty Research Award Lecture featuring C. Nataraj, Ph.D.

Scholarship@Villanova - Outstanding Faculty Research Award Lecture featuring C. Nataraj, Ph.D.

When a killer infection spreads in the movies, the doctors triage and isolate the patients while a medical biologist races to diagnose the illness and find a cure. Inevitably a national emergency follows as the virus or bacteria wipe out an unsuspecting population. While this may be Hollywood's vision, Reg Beer, the Medical Diagnostics Initiative Leader at Lawrence Livermore National Laboratory, explains the Lab-on-Chip technologies he develops for time-critical Molecular Diagnostics applications. Series: "Lawrence Livermore National Lab Science on Saturday" [Science] [Show ID: 25750]

When a killer infection spreads in the movies, the doctors triage and isolate the patients while a medical biologist races to diagnose the illness and find a cure. Inevitably a national emergency follows as the virus or bacteria wipe out an unsuspecting population. While this may be Hollywood's vision, Reg Beer, the Medical Diagnostics Initiative Leader at Lawrence Livermore National Laboratory, explains the Lab-on-Chip technologies he develops for time-critical Molecular Diagnostics applications. Series: "Lawrence Livermore National Lab Science on Saturday" [Science] [Show ID: 25750]

Presented by Michael D. Wider, PhD

Presented by Michael Wider, PhD

This week in the Planet Earth Podcast: a look at how technology designed to measure air pollution may soon be used to smell disease on a patient's breath; and the steps British researchers are taking to put a value on all the benefits of nature that we often take for granted.

This week in the Planet Earth Podcast: a look at how technology designed to measure air pollution may soon be used to smell disease on a patient's breath; and the steps British researchers are taking to put a value on all the benefits of nature that we often take for granted. Like this podcast? Please help us by supporting the Naked Scientists

This week in the Planet Earth Podcast: a look at how technology designed to measure air pollution may soon be used to smell disease on a patient's breath; and the steps British researchers are taking to put a value on all the benefits of nature that we often take for granted. Like this podcast? Please help us by supporting the Naked Scientists

The Taught MSc Degree in Biomedical Science is a part-time course aimed at Biomedical Science and Life Science graduates. It is particularly suitable for Medical Scientists working in a clinical setting, but is equally relevant to individuals interested in any area of Medical Diagnostics for example in the Biotech or Biopharmaceutical sectors.

While histopathology of excised tissue remains the gold standard for diagnosis, several new, non-invasive diagnostic techniques are being developed. They rely on physical and biochemical changes that precede and mirror malignant change within tissue. The basic principle involves simple optical techniques of tissue interrogation. Their accuracy, expressed as sensitivity and specificity, are reported in a number of studies suggests that they have a potential for cost effective, real-time, in situ diagnosis. We review the Third Scientific Meeting of the Head and Neck Optical Diagnostics Society held in Congress Innsbruck, Innsbruck, Austria on the 11th May 2011. For the first time the HNODS Annual Scientific Meeting was held in association with the International Photodynamic Association (IPA) and the European Platform for Photodynamic Medicine (EPPM). The aim was to enhance the interdisciplinary aspects of optical diagnostics and other photodynamic applications. The meeting included 2 sections: oral communication sessions running in parallel to the IPA programme and poster presentation sessions combined with the IPA and EPPM posters sessions.

Wed, 8 Dec 2010 12:00:00 +0100 https://edoc.ub.uni-muenchen.de/12764/ https://edoc.ub.uni-muenchen.de/12764/2/Kohlmann_Mareike.pdf Kohlmann, Mareike ddc:000, ddc:004, Fakultät für Mathematik, Informati